These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39128420)

  • 21. Face validity of the ICD-10 criteria of substance abuse and dependence for patients prescribed cannabis-based medicines for chronic pain-A survey of pain medicine physicians in Canada, Germany and Israel.
    Lauff S; Petzke F; Brill S; Schouten L; Fitzcharles MA; Pereira JX; Häuser W
    Eur J Pain; 2023 May; 27(5):588-601. PubMed ID: 36692097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis use disorder in patients with chronic pain: overestimation and underestimation in a cross-sectional observational study in 3 German pain management centres.
    Bialas P; Böttge-Wolpers C; Fitzcharles MA; Gottschling S; Konietzke D; Juckenhöfel S; Madlinger A; Welsch P; Häuser W
    Pain; 2023 Jun; 164(6):1303-1311. PubMed ID: 36327134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization of medicinal cannabis for pain by individuals with spinal cord injury.
    Stillman M; Capron M; Mallow M; Ransom T; Gustafson K; Bell A; Graves D
    Spinal Cord Ser Cases; 2019; 5():66. PubMed ID: 31632724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors Associated with Medical Cannabis Use After Certification: A Three-Month Longitudinal Study.
    Zhang C; Slawek DE; Ross J; Zolotov Y; Castillo F; Levin FR; Sohler NL; Minami H; Cunningham CO; Starrels JL; Arnsten JH
    Cannabis Cannabinoid Res; 2024 Jun; 9(3):e859-e869. PubMed ID: 36961410
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the psychometric properties of the cannabis use disorders identification test - revised among college students.
    Schultz NR; Bassett DT; Messina BG; Correia CJ
    Addict Behav; 2019 Aug; 95():11-15. PubMed ID: 30798191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study.
    Haroutounian S; Ratz Y; Ginosar Y; Furmanov K; Saifi F; Meidan R; Davidson E
    Clin J Pain; 2016 Dec; 32(12):1036-1043. PubMed ID: 26889611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R).
    Adamson SJ; Kay-Lambkin FJ; Baker AL; Lewin TJ; Thornton L; Kelly BJ; Sellman JD
    Drug Alcohol Depend; 2010 Jul; 110(1-2):137-43. PubMed ID: 20347232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical cannabis and cognitive performance in middle to old adults treated for chronic pain.
    Sznitman SR; Vulfsons S; Meiri D; Weinstein G
    Drug Alcohol Rev; 2021 Feb; 40(2):272-280. PubMed ID: 32964502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
    Lintzeris N; Mills L; Abelev SV; Suraev A; Arnold JC; McGregor IS
    Harm Reduct J; 2022 Jul; 19(1):88. PubMed ID: 35907959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid and Cannabis Co-Use among Adults With Chronic Pain: Relations to Substance Misuse, Mental Health, and Pain Experience.
    Rogers AH; Bakhshaie J; Buckner JD; Orr MF; Paulus DJ; Ditre JW; Zvolensky MJ
    J Addict Med; 2019; 13(4):287-294. PubMed ID: 30557213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical cannabis treatment for chronic pain: Outcomes and prediction of response.
    Aviram J; Pud D; Gershoni T; Schiff-Keren B; Ogintz M; Vulfsons S; Yashar T; Adahan HM; Brill S; Amital H; Goor-Aryeh I; Robinson D; Green L; Segal R; Fogelman Y; Tsvieli O; Yellin B; Vysotski Y; Morag O; Tashlykov V; Sheinfeld R; Goor R; Meiri D; Eisenberg E
    Eur J Pain; 2021 Feb; 25(2):359-374. PubMed ID: 33065768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis.
    Aviram J; Lewitus GM; Pud D; Procaccia S; Berman P; Yellin B; Vysotski Y; Hazan O; Eisenberg E; Meiri D
    Pharmacol Res; 2021 Jul; 169():105651. PubMed ID: 34000362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms.
    Gruber SA; Smith RT; Dahlgren MK; Lambros AM; Sagar KA
    Exp Clin Psychopharmacol; 2021 Apr; 29(2):147-156. PubMed ID: 33764103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age Invariance of the Cannabis Abuse Screening Test in a Probabilistic Sample of Cannabis Users.
    Legleye S; Rouquette A
    Eur Addict Res; 2018; 24(1):37-42. PubMed ID: 29495016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabis and Cannabinoids for Chronic Pain.
    Romero-Sandoval EA; Kolano AL; Alvarado-Vázquez PA
    Curr Rheumatol Rep; 2017 Oct; 19(11):67. PubMed ID: 28983880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of medical cannabis use on physical and psychiatric symptoms across the day among older adults.
    Dvorak RD; Paulson D; Dunn ME; Burr EK; Peterson R; Maynard M; De Leon AN; Klaver SJ; Leary AV; Hayden ER; Allen Q; Toth E
    Psychiatry Res; 2024 Sep; 339():116055. PubMed ID: 38924900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical cannabis use among patients with chronic pain in an interdisciplinary pain rehabilitation program: Characterization and treatment outcomes.
    Shah A; Craner J; Cunningham JL
    J Subst Abuse Treat; 2017 Jun; 77():95-100. PubMed ID: 28476279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review.
    Okusanya BO; Asaolu IO; Ehiri JE; Kimaru LJ; Okechukwu A; Rosales C
    Syst Rev; 2020 Jul; 9(1):167. PubMed ID: 32723354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of marijuana exclusively for medical purposes.
    Wall MM; Liu J; Hasin DS; Blanco C; Olfson M
    Drug Alcohol Depend; 2019 Feb; 195():13-15. PubMed ID: 30557813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Medical Cannabis on Pain Level and Quality of Sleep among Rheumatology Clinic Outpatients.
    Habib G; Khazin F; Artul S
    Pain Res Manag; 2021; 2021():1756588. PubMed ID: 34531934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.